Rebecca R. Arcos

Statistics

Publications

Citations

170

H-Index

Active since

2005

Affiliations

Eli Lilly (United States)(Current)

Rebecca R. Arcos is an author at Eli Lilly (United States) specializing in oncogenic stress responses, tumor microenvironment effects, and viral genome packaging.

Publications per year

2005–2015

Publications

A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer

Amita Patnaik, Paul Haluska, Anthony W. Tolcher et al. · Clinical Cancer Research · 2015 · 138 citations

Medicine, Oncology, Pharmacology +14

Interaction of the adenovirus major core protein precursor, pVII, with the viral DNA packaging machinery

Wei Zhang, Rebecca R. Arcos · Virology · 2005 · 32 citations

Life Sciences, Biology, Molecular Biology +14

1–2 of 2